Censo Bio is a leader in creating relevant, customizable human neurological and inflammatory disease models with induced pluripotent stem cells (iPSC). With deep expertise in neuroscience, immunology, stem cell biology and gene editing, Censo Biotechnologies specializes in model and assay design for drug discovery. Censo has the ability to select or engineer the desired human genetic background by creating iPSC from patient samples or using CRISPR for gene editing. We have established robust, propriety differentiation protocols for sensory and excitatory cortical neurons, astrocytes, microglia, macrophages, monocytes, and dendritic cells as well as co-cultures. We also offer a host of phenotypic and screening assays which can be customized or developed specifically for your needs. We employ rigorous QC measures and maintain comprehensive SOPs and documentation.